ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Ubsetf Uc98

Ubsetf Uc98 (UC98)

1,180.50
2.50
(0.21%)
Cerrado 30 Julio 10:30AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
1,180.50
Postura de Compra
1,179.50
Postura de Venta
1,181.50
Volume Operado de la Acción
84
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
1,178.00
Precio de Apertura
-
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

UC98 Últimas noticias

MAP Pharmaceuticals Announces Initiation of LEVADEX(TM) Pharmacokinetics Trial

--Trial to be used in support of NDA submission-- MOUNTAIN VIEW, Calif., Feb. 16 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the Company initiated a...

MAP Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Jan. 6 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the company will present at the 28th Annual J.P. Morgan Healthcare Conference...

MAP Pharmaceuticals Secures $60 Million Committed Equity Financing Facility

MOUNTAIN VIEW, Calif., Nov. 12 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has secured a committed equity financing facility under which it may sell...

MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference

MOUNTAIN VIEW, Calif., Nov. 11 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the company will present at the Lazard Capital Markets 6th Annual Healthcare...

MAP Pharmaceuticals Completes Interim Safety Review of LEVADEX(TM) Open-Label Safety Extension in More Than 400 Patients

MOUNTAIN VIEW, Calif., Oct. 29 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has completed a planned interim safety review of the open-label...

MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of

-- Analysis Shows Potential of LEVADEX to Treat a Broad Spectrum of Migraine -- -- Company to Host Webcast on Monday, September 14th at 7:15 a.m. ET -- MOUNTAIN VIEW, Calif., Sept. 10...

MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences

- Investor Webcast to Discuss Phase 3 LEVADEX(TM) Data Presented in Late-Breaking Session at the 14th Congress of the International Headache Society - MOUNTAIN VIEW, Calif., Sept. 2...

AstraZeneca Terminates MAP Pharma Pact, Sees $44 Million charge In 2Q

AstraZeneca PLC (AZN), a major international healthcare business, said Thursday it has terminated the license agreement with MAP Pharmaceuticals Inc (MAPP), regarding Unit Dose Budesonide, or UDB...

MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration

- Company to Suspend Development of UDB - MOUNTAIN VIEW, Calif., July 9 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has received a notice of...

MAP Pharmaceuticals Announces Pricing of Its Initial Public Offering

MOUNTAIN VIEW, Calif., Oct. 5 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. announced today that it has priced its initial public offering of 5,000,000 shares of common stock at a price of...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TWOU2U Inc
US$ 2.70
(116.00%)
139.18M
LIPOLipella Pharmaceuticals Inc
US$ 0.8576
(112.22%)
194.69M
NIPGNIP Group Inc
 16.50
(82.93%)
7.04M
TIVCTivic Health Systems Inc
US$ 0.7049
(55.95%)
106.15M
ISPOInspirato Inc
US$ 5.15
(47.99%)
6.24M
CGTXCognition Therapeutics Inc
US$ 1.32
(-44.30%)
26.32M
GRIGRI Bio Inc
US$ 0.8334
(-33.86%)
1.14M
CEROCERo Therapeutics Holdings Inc
US$ 0.1817
(-29.02%)
8.28M
PRSTPresto Technologies Inc
US$ 0.0499
(-26.51%)
29.32M
TGLTreasure Global Inc
US$ 1.40
(-24.32%)
80.79k
NVDANVIDIA Corporation
US$ 111.59
(-1.30%)
248.03M
LIPOLipella Pharmaceuticals Inc
US$ 0.8576
(112.22%)
194.69M
SQQQProShares UltraPro Short QQQ
US$ 9.05
(-0.55%)
152.03M
TWOU2U Inc
US$ 2.70
(116.00%)
139.18M
TSLATesla Inc
US$ 232.10
(5.60%)
129.2M
Acme Investments Acme Investments 4 minutos hace
Nothing shows a bottom here without any catalyst!! Most of the otc is in limbo waiting for the Donald to take the throne!!
NSAV
littlejohn littlejohn 9 minutos hace
CAAS may drop 80 cents Wednesday open

when it goes ex dividend...

but missing another 5% Monday

is pure dee bad timing...

Sure don't believe that the share price

will hold at the ex dividend start point

though,
powerbattles powerbattles 12 minutos hace
DD_dempsey Let’s clarify the situation with the specifics you’ve provided:

Clarified Scenario Entities:

Apollo: The newly created company that is acquiring both KOAN and EMGE.
KOAN (Ticker KOAN): The company being acquired by Apollo.
EMGE (Ticker EMGE): T
EMGE
Biotechotcguy Biotechotcguy 17 minutos hace
Anyone know what their plan is to increase shareholder value?
BLPG
Ayock Ayock 19 minutos hace
Speaking directly to you...

https://scontent-sea1-1.xx.fbcdn.net/v/t39.30808-6/453382690_880106260830085_7153664334127032793_n.jpg?_nc_cat=109&ccb=1-7&_nc_sid=833d8c&_nc_ohc=kNU1L6UkqgAQ7kNvgEQizJJ&_nc_ht=scontent-sea1-1.xx&oh=00_AYAfJDVDVjzTDCnQj0RV9oy7jcdhxYZCef0TkFZrEArZdA&oe=66AE3
JamesLH JamesLH 19 minutos hace
There you go LYING again. Nick Campanella was NAMED in a federal criminal indictment as a co-conspirator in a criminal complaint. Specifically, Campanella FORGED letters claiming he had supplies of 3M masks when in fact he did not.

This is not disputable, you're the only one who seems
SNPW
littlejohn littlejohn 19 minutos hace
Etrade has a savings account paying

a higher rate than that...

guess you actually get it from M.S...

Pays to shop around...

You may not want to lock it up long...

So we watch...LJ
shoondale shoondale 19 minutos hace
Or the third option of revenues as unthinkable, for your narrative, as that may seem. Which is why your scenario has not happened to date.
"TC Special Investments was still owed $ 880,355 as of 3/31/2024. Based on the discount conversion rate of 10% and 25% of the lowest price for the last 90
MWWC
newmedman newmedman 23 minutos hace
not one mention of scorched earth policy or a personal attack on anyone. It was really quite refreshing and not what I was expecting. Faith almost restored. 😘😘
littlejohn littlejohn 23 minutos hace
2.99/gallon price at Wally World pumps

on Sunday...

busy service station but the store

was slow in mid afternoon...

surprised me, but there were still

folks shopping...

Still not seeing a reason on highways
hookrider hookrider 24 minutos hace
rooster: Trump & Vance The Weird-O's!!!!!!
Bright Boy Bright Boy 29 minutos hace
Andrew Left arraigned this afternoon:

https://www.bloomberg.com/news/articles/2024-07-30/andrew-left-pleads-not-guilty-setting-up-fight-over-short-sales

This is just the beginning!The irony is that Andrew is now the "BAIT" to capture his fellow predators instead of the
NWBO
palaypu0406 palaypu0406 31 minutos hace
yes Karlacorn, It is..
ITUP
carlson carlson 31 minutos hace
What??? Soon??? How soon???
NSAV
karlacorn3 karlacorn3 33 minutos hace
Thanks, Laxmi. By "Circular" you are referring to the Grant Release Notice, correct?
K
ITUP
DogsOverPeople DogsOverPeople 35 minutos hace
Hhahhahahhahahahahahhahahhahahhahhahahahhahahahahahhahahaha
UATG
skitahoe skitahoe 38 minutos hace
I was at my neurologist's today and happened to ask her if she was familiar with AVXL's Alzheimer's drug, she hadn't. I told her it slowed brain shrinkage in the trial, that interested her, but she indicated it must be approved. I told her they were going for it in Europe first and she told me tha
AVXL NWBO
IH Geek [Tom] IH Geek [Tom] 38 minutos hace
How does this work? Shouldn't it be sorted by the highest percentage change on down to the lowest of the Top Gainers?

I'm not following this, please advise, thanks! I have Real Time... 😺

https://ih.advfn.com/markets/nasdaq/premarket/gainers

HoldEm777 HoldEm777 39 minutos hace
All they have to do in my opinion is prove CIVET USA is not BS. Produce anything at all showing it’s real and Emilia actually owned it as they say. But they are building a story on a foundation that does not exist
NWPN
Acme Investments Acme Investments 39 minutos hace
First things first!!
BCAP
palaypu0406 palaypu0406 39 minutos hace
Dear Karlacorn,
Circular will be released today...
Budget, I have already circulated the rough budget to the staff and internal group blog...
But we need to now incorporate sales and inventory adjustments given the underwriting commitment from the banking group..

ITUP
sharkey1 sharkey1 40 minutos hace
Update on the Accord trial
https://www.pacermonitor.com/public/case/53616923/Purdue_Pharma_LP_et_al_v_Accord_Healthcare_Inc_et_al
ELTP

Su Consulta Reciente

Delayed Upgrade Clock